Skip to main content
. Author manuscript; available in PMC: 2016 Jan 15.
Published in final edited form as: Clin Cancer Res. 2014 Nov 25;21(2):303–311. doi: 10.1158/1078-0432.CCR-14-1781

Figure 1. Urinary IL-2 and IL-8 in patients treated with sequential MMC + BCG or BCG monotherapy.

Figure 1

Urine cytokines were measured at second void following intravesical administration. A. Median (IQR) urinary IL-2 in patients treated with sequential MMC + BCG. B. Median (IQR) urinary IL-2 in patients treated with BCG monotherapy. C. Median (IQR) urinary IL-8 in patients treated with sequential MMC + BCG. D. Median (IQR) urinary IL-8 in patients treated with BCG monotherapy.